WHO ICTRP trial
Celecoxib Add-On Therapy Compared to Haloperidol Alone in Schizophrenia: A…
IRCT138809201457N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT138809201457N6 |
|---|---|
| Public title | Celecoxib Add-On Therapy Compared to Haloperidol Alone in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial |
| Scientific title | Celecoxib Add-On Therapy Compared to Haloperidol Alone in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial |
| Primary sponsor | Mazandaran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 4 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Schizophrenia. Schizophrenia;Schizophrenia |
| Interventions | Intervention 1: Haloperidoloral, 15-30 mg/day, orally, plus Celecoxib, 400 mg/day for 5 weeks. Intervention 2: Haloperidoloral, 15-30 mg/day, orally, plus placebo for 5 weeks.;Treatment - Drugs;Treatment - Drugs;Haloperidoloral, 15-30… |
| Registration date | Nov 2, 2010 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: